Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

2010911 citationsJournal Articlebronze Open Access

Authors

Steven R. Smith · Translational Research Institute for Metabolism and Diabetes

Neil J. Weissman · Washington Hospital

Christen M. Anderson · Arena Pharmaceuticals (United States)

Matilde Sanchez · Arena Pharmaceuticals (United States)

Emil Chuang · Arena Pharmaceuticals (United States)

Scott Stubbe · Arena Pharmaceuticals (United States)

Harold Bays

Abstract

In conjunction with behavioral modification, lorcaserin was associated with significant weight loss and improved maintenance of weight loss, as compared with placebo. (Funded by Arena Pharmaceuticals; ClinicalTrials.gov number, NCT00395135.)

Topics & Keywords

Pharmacology and Obesity Treatment Hormonal and reproductive studies Cardiovascular Syncope and Autonomic Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 363, Issue 3, pp. 245-256

DOI: 10.1056/nejmoa0909809

Field-Weighted Citation Impact: 55.94